Elevated eosinophils proportion as predictor of immune‐related adverse events after ipilimumab and nivolumab treatment of advanced and metastatic renal cell carcinoma
暂无分享,去创建一个
T. Naiki | T. Etani | N. Kawai | T. Yasui | Y. Moritoki | S. Hamamoto | A. Okada | K. Taguchi | S. Kurokawa | Hiroki Kubota | K. Kimura | Yoshihiko Tasaki | Yusuke Noda | N. Tomiyama | N. Matsuyama | Yoshihisa Mimura | Satoshi Nozaki | M. Aoki | Y. Sugiyama | Yasuhito Sue | Y. Tasaki